Skip to content
CAMP Logo
PennMedicine Logo
  • Clinical
    • Medications for Opioid Use Disorder (MOUD)
      • Buprenorphine Low-Dose Induction using a Cross-Tapering Strategy
      • Methadone Resources for Providers
    • Pain or Opioid Withdrawal in Hospitalized Patients
    • Xylazine Withdrawal and Overdose
    • Xylazine Wounds
    • Alcohol Use
    • Medetomidine
    • Substance Use Navigator Team
    • Success Stories
    • Penn Addiction Resources
  • Education
    • Students
      • President’s Engagement Prize
    • Trainings
    • Addiction Medicine Fellowship
    • All About the X Waiver
    • Working as a Peer in Recovery
    • Events
  • Community & Harm Reduction Resources
    • Community
      • Community Advisory Board (CAB)
      • Sustaining Peers in the ED (SPED)
      • Reentry Citizens
    • Harm Reduction
      • All About Fentanyl
      • All About Xylazine
      • How to Use Narcan
      • How to Mitigate Stigma
    • One-Page Resources
    • Volunteer & Events Calendar
      • Join Us at Outreach Events!
      • Volunteer Harm Reduction Interest Group
  • Our Work
    • CareConnect Warmline
    • Addiction Medicine Consult Service
    • Police-Assisted Diversion (PAD)
    • Project HOME
    • PROUD Clinic
    • Research
      • NACCHO
    • News
    • Policy
      • In Hospital Use Guidelines
    • Publications
    • Clinical Trials
  • About Us
    • Leadership
    • Advisory Board
    • Faculty
    • CAMP Team
    • Team Spotlight
    • Newsletters
    • Donate
  • Get Help

Tag: policy change

Nearly All Doctors Will be able to Prescribe Buprenorphine

Posted on January 18, 2021 by bsalerno

Trump administration will let nearly all doctors prescribe addiction medicine buprenorphine

Posted in UncategorizedTagged buprenorphine, policy change, prescribing

Quick Links

Call the CareConnect Warmline

Micro-Dosing Guide

Addiction Medicine Fellowship

Resources

 

Contact Us:

484-278-1679

Email Address:

penncamp
@pennmedicine.upenn.edu

footer-bg
Center for Addiction Medicine and Policy

Contact Us with Questions or to Stay Informed of Upcoming Events
© 2025, Center for Addiction Medicine and Policy
  • Clinical
    • Medications for Opioid Use Disorder (MOUD)
      • Buprenorphine Low-Dose Induction using a Cross-Tapering Strategy
      • Methadone Resources for Providers
    • Pain or Opioid Withdrawal in Hospitalized Patients
    • Xylazine Withdrawal and Overdose
    • Xylazine Wounds
    • Alcohol Use
    • Medetomidine
    • Substance Use Navigator Team
    • Success Stories
    • Penn Addiction Resources
  • Education
    • Students
      • President’s Engagement Prize
    • Trainings
    • Addiction Medicine Fellowship
    • All About the X Waiver
    • Working as a Peer in Recovery
    • Events
  • Community & Harm Reduction Resources
    • Community
      • Community Advisory Board (CAB)
      • Sustaining Peers in the ED (SPED)
      • Reentry Citizens
    • Harm Reduction
      • All About Fentanyl
      • All About Xylazine
      • How to Use Narcan
      • How to Mitigate Stigma
    • One-Page Resources
    • Volunteer & Events Calendar
      • Join Us at Outreach Events!
      • Volunteer Harm Reduction Interest Group
  • Our Work
    • CareConnect Warmline
    • Addiction Medicine Consult Service
    • Police-Assisted Diversion (PAD)
    • Project HOME
    • PROUD Clinic
    • Research
      • NACCHO
    • News
    • Policy
      • In Hospital Use Guidelines
    • Publications
    • Clinical Trials
  • About Us
    • Leadership
    • Advisory Board
    • Faculty
    • CAMP Team
    • Team Spotlight
    • Newsletters
    • Donate
  • Get Help